Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer

1 Dec 2021

Abstract excerpt

BACKGROUND: Circulating tumor DNA (ctDNA) is a promising diagnostic and prognostic marker for many cancers and has been actively investigated in recent years. Previous studies have already demonstrated the potential use of ctDNA methylation markers in the diagnosis and prognostication of colorectal cancer (CRC). This retrospective study validated the value of methylation biomarker MYO1-G (cg10673833) in CRC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34961566
DOI: 10.1186/s13148-021-01216-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancerPMID 34961566Read ↗

Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation studySemantic proximity Read ↗

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and predictionSemantic proximity Read ↗

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineSemantic proximity Read ↗

Evaluation of epigenetic methylation biomarkers for the detection of colorectal cancer using droplet digital PCRSemantic proximity Read ↗

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control studySemantic proximity Read ↗

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer BiomarkerSemantic proximity Read ↗

Cell-free DNA methylation profiles enable early detection of colorectal and gastric cancerSemantic proximity Read ↗

Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal CancerSemantic proximity Read ↗

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancerSemantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literatureSemantic proximity Read ↗

DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.